Full-dose cisplatin chemotherapy combined with hemodialysis in a patient with impaired renal function and a mediastinal germ cell tumor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Full-dose cisplatin chemotherapy combined with hemodialysis in a patient with impaired renal function and a mediastinal germ cell tumor

Published:2020-01-31 Issue:9 Volume:31 Page:983-987
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Jager Nynke G.L.,Sari Vicdan,Westermann Anneke M.,Bijleveld Yuma A.,Bijlsma Joost A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference21 articles.

1. Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.;Schellens;Br J Cancer,1996

2. Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity.;Reece;J Clin Oncol,1987

3. Cisplatin nephrotoxicity: a review of the literature.;Manohar;J Nephrol,2018

4. Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment.;Ogawa;Int J Clin Oncol,2013

5. Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function.;Kintzel;Cancer Treat Rev,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models;BMC Cancer;2023-06-02

2. A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models;2022-11-11

3. Cisplatin/etoposide;Reactions Weekly;2022-07

4. Successful treatment of a patient with renal failure, treated with haemodialysis, and advanced ovarian germ cell tumour using modified cisplatin-based chemotherapy duplet;ecancermedicalscience;2022-05-23

5. Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review;Expert Opinion on Drug Metabolism & Toxicology;2020-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3